Bindu Murthy
Bristol-Myers Squibb (United States)(US)Bristol-Myers Squibb (Belgium)(BE)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, Atrial Fibrillation Management and Outcomes
Most-Cited Works
- → Pharmacokinetic Interactions of Topiramate(2004)182 cited
- → Pharmacokinetics and Pharmacodynamics of Ceftobiprole, an Anti-MRSA Cephalosporin with Broad-Spectrum Activity(2008)106 cited
- → First‐in‐human study of deucravacitinib: A selective, potent, allosteric small‐molecule inhibitor of tyrosine kinase 2(2022)53 cited
- → Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis(2014)43 cited
- → Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects(2016)43 cited
- → Soft-Tissue Penetration of Ceftobiprole in Healthy Volunteers Determined by In Vivo Microdialysis(2009)39 cited